Pesticides & Agrochemicals · Founded 1986 · www.naclind.com · BSE 524709 · NSE NACLIND · ISIN INE295D01020
No Notes Added Yet
Business
NACL Industries Ltd. is an Indian company engaged in the manufacturing and marketing of agrochemicals, primarily for crop protection. Its core business involves the development, synthesis, and formulation of various pesticides, including insecticides, herbicides, fungicides, and plant growth regulators. The company serves the agricultural sector by providing solutions that help farmers protect their crops from pests and diseases, thereby improving yield and quality. NACL Industries makes money by selling these crop protection products to distributors, retailers, and directly to farmers across India, and potentially through exports.
Revenue Mix
While specific revenue contributions are not publicly detailed, NACL Industries' business typically segments into:
Technical Products: Manufacturing active pharmaceutical ingredients (APIs) or technical grade pesticides, which are the concentrated raw materials used in formulations. These can be sold to other formulators or used internally.
Formulations: Developing and manufacturing finished crop protection products ready for use by farmers. This segment includes a wide range of branded insecticides, herbicides, fungicides, and plant growth regulators tailored for different crops and regions.
The revenue mix is likely dominated by sales of formulations, given their direct market presence.
Industry
The Pesticides & Agrochemicals industry in India is characterized by its reliance on agricultural output, monsoon patterns, and government policies. It is a competitive market with a mix of large multinational corporations, established domestic players, and smaller regional manufacturers. NACL Industries operates as a mid-tier player, focusing on a broad portfolio of products, including both generic and proprietary formulations. Its positioning relies on its manufacturing capabilities, R&D efforts for new product development, and its distribution network to reach farmers across various agricultural regions of India.
MOAT
NACL Industries' competitive advantages, though not as strong as a deep economic moat, likely stem from:
Manufacturing Capabilities & Scale: Established production facilities and backward integration in some technical products can offer cost efficiencies.
Distribution Network: A well-developed network across diverse agricultural regions in India is crucial for market penetration and farmer access.
Product Portfolio: A wide range of formulations targeting various crops and pest issues provides a broad market appeal and mitigates reliance on a single product.
Registrations & Regulatory Expertise: Navigating the complex regulatory environment for product registrations is a barrier to entry for new players.
Growth Drivers
Key factors that can drive NACL Industries' growth over the next 3-5 years include:
Growth in Indian Agriculture: Increasing food demand and government focus on boosting agricultural productivity will drive demand for agrochemicals.
Product Innovation & Diversification: Introduction of new, effective, and environmentally safer formulations and technicals can capture market share.
Expanding Distribution Reach: Deepening market penetration, especially in untapped or under-served agricultural pockets.
Export Opportunities: Leveraging manufacturing capabilities to cater to international markets, reducing dependence on domestic agricultural cycles.
Increased Awareness: Growing farmer awareness regarding the benefits of scientific crop protection for yield enhancement.
Risks
Monsoon Dependence: The performance of the agricultural sector and, consequently, demand for agrochemicals, is heavily reliant on timely and adequate monsoons.
Raw Material Price Volatility: Fluctuations in the prices of crude oil and other chemical intermediates can impact manufacturing costs and margins.
Regulatory Changes: Stringent environmental regulations or bans on certain pesticides can significantly impact product portfolios and business operations.
Intense Competition & Pricing Pressure: The presence of numerous domestic and international players can lead to pricing pressure and margin erosion.
Counterfeit Products: The prevalence of spurious products in the market can dilute brand value and impact sales.
Management & Ownership
NACL Industries Ltd. is typically promoted and managed by its founding family or a core promoter group, which is common among Indian companies. The management team likely comprises individuals with significant experience in the agrochemical industry, possessing technical expertise and market understanding. The ownership structure generally includes a substantial promoter holding, alongside institutional investors (domestic and foreign) and public shareholders. The quality of management is crucial for navigating industry specific challenges and capitalizing on growth opportunities.
Outlook
NACL Industries operates in a fundamental sector tied to India's agricultural economy. The bull case rests on continued growth in Indian agriculture, aided by government initiatives, increasing farmer awareness, and the company's ability to innovate and expand its product portfolio and distribution network. Favorable monsoon seasons and stable raw material costs would also contribute positively. The bear case involves risks such as erratic monsoon patterns leading to subdued agricultural output, intense competitive pressure on pricing, adverse regulatory actions, and significant volatility in raw material costs impacting profitability. Overall, the company's performance is likely to be influenced by the cyclical nature of agriculture and its ability to maintain a competitive edge through product development and market reach.
| #(Fig in Cr.) | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 457 | 325 | 440 | 268 | 201 | 448 | 457 | 318 | 361 | 383 |
| Other Income | 4 | 3 | 3 | 1 | 1 | 1 | -0 | 0 | 2 | 2 |
| Total Income | 461 | 328 | 444 | 269 | 202 | 450 | 457 | 318 | 363 | 385 |
| Total Expenditure | 446 | 329 | 400 | 294 | 275 | 410 | 412 | 312 | 348 | 342 |
| Operating Profit | 14 | -1 | 44 | -25 | -73 | 39 | 45 | 7 | 15 | 43 |
| Interest | 19 | 18 | 17 | 15 | 14 | 14 | 13 | 12 | 7 | 6 |
| Depreciation | 7 | 7 | 7 | 7 | 8 | 7 | 8 | 8 | 9 | 9 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 1 | 29 | 0 | -17 | 0 | 0 | 0 |
| Profit Before Tax | -12 | -26 | 20 | -47 | -66 | 18 | 6 | -14 | -1 | 28 |
| Provision for Tax | -2 | -6 | 5 | -10 | -16 | 5 | 4 | -3 | -0 | 7 |
| Profit After Tax | -9 | -20 | 15 | -36 | -50 | 13 | 3 | -10 | -1 | 21 |
| Adjustments | 0 | -1 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | -9 | -21 | 15 | -36 | -50 | 13 | 3 | -10 | -1 | 21 |
| Adjusted Earnings Per Share | -0.4 | -1 | 0.7 | -1.7 | -2.3 | 0.6 | 0.1 | -0.4 | -0 | 0.9 |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 692 | 735 | 847 | 865 | 1015 | 1191 | 1633 | 2116 | 1779 | 1235 | 1584 | 1519 |
| Other Income | 19 | 17 | 21 | 35 | 16 | 24 | 17 | 15 | 14 | 13 | 8 | 4 |
| Total Income | 710 | 751 | 868 | 901 | 1031 | 1216 | 1650 | 2130 | 1793 | 1248 | 1592 | 1523 |
| Total Expenditure | 636 | 680 | 800 | 861 | 955 | 1088 | 1496 | 1928 | 1767 | 1303 | 1487 | 1414 |
| Operating Profit | 75 | 71 | 68 | 39 | 76 | 127 | 154 | 203 | 26 | -55 | 106 | 110 |
| Interest | 37 | 38 | 33 | 34 | 29 | 28 | 27 | 47 | 76 | 65 | 46 | 38 |
| Depreciation | 27 | 28 | 20 | 20 | 24 | 25 | 25 | 28 | 27 | 29 | 32 | 34 |
| Exceptional Income / Expenses | 0 | 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29 | -17 | -17 |
| Profit Before Tax | 11 | 32 | 15 | -13 | 24 | 75 | 100 | 128 | -76 | -119 | 10 | 19 |
| Provision for Tax | 2 | -1 | 4 | -7 | 7 | 24 | 26 | 34 | -17 | -27 | 5 | 8 |
| Profit After Tax | 9 | 33 | 12 | -7 | 17 | 51 | 73 | 95 | -59 | -92 | 5 | 13 |
| Adjustments | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 10 | 33 | 12 | -7 | 17 | 51 | 73 | 95 | -59 | -92 | 5 | 13 |
| Adjusted Earnings Per Share | 0.6 | 1.9 | 0.7 | -0.4 | 0.8 | 2.4 | 3.4 | 4.4 | -2.7 | -4.2 | 0.2 | 0.6 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 28% | -9% | 6% | 9% |
| Operating Profit CAGR | 0% | -19% | -4% | 4% |
| PAT CAGR | 0% | -63% | -37% | -6% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -35% | 21% | 13% | 19% |
| ROE Average | 1% | -10% | 1% | 4% |
| ROCE Average | 6% | 0% | 6% | 9% |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 186 | 229 | 239 | 284 | 357 | 419 | 488 | 574 | 511 | 427 | 683 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 36 | 30 | 20 | 12 | 22 | 71 | 172 | 203 | 149 | 85 | 0 |
| Other Non-Current Liabilities | 34 | 24 | 22 | 14 | 22 | 32 | 23 | 21 | 5 | -14 | 0 |
| Total Current Liabilities | 356 | 374 | 432 | 435 | 560 | 468 | 831 | 1115 | 1143 | 687 | 647 |
| Total Liabilities | 611 | 657 | 713 | 745 | 961 | 990 | 1516 | 1914 | 1808 | 1185 | 1331 |
| Fixed Assets | 167 | 163 | 158 | 141 | 191 | 220 | 238 | 402 | 439 | 439 | 459 |
| Other Non-Current Assets | 29 | 26 | 25 | 45 | 73 | 59 | 147 | 100 | 82 | 80 | 47 |
| Total Current Assets | 416 | 468 | 530 | 558 | 698 | 712 | 1130 | 1412 | 1288 | 666 | 825 |
| Total Assets | 611 | 657 | 713 | 745 | 961 | 990 | 1516 | 1914 | 1808 | 1185 | 1331 |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 12 | 13 | 8 | 7 | 7 | 84 | 68 | 70 | 41 | 32 | 57 |
| Cash Flow from Operating Activities | 46 | 58 | 24 | 36 | 103 | 83 | -124 | -20 | 50 | 469 | -104 |
| Cash Flow from Investing Activities | -12 | -6 | -14 | -27 | -97 | 14 | -163 | -142 | -38 | 4 | -58 |
| Cash Flow from Financing Activities | -33 | -58 | -11 | -9 | 70 | -113 | 290 | 135 | -22 | -448 | 108 |
| Net Cash Inflow / Outflow | 1 | -5 | -1 | 0 | 77 | -16 | 2 | -28 | -9 | 25 | -55 |
| Closing Cash & Cash Equivalent | 14 | 8 | 7 | 7 | 84 | 68 | 70 | 41 | 32 | 57 | 3 |
| # | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 0.57 | 1.92 | 0.68 | -0.38 | 0.8 | 2.38 | 3.39 | 4.37 | -2.71 | -4.2 | 0.2 |
| CEPS(Rs) | 2.09 | 3.57 | 1.84 | 0.73 | 1.94 | 3.56 | 4.55 | 5.67 | -1.46 | -2.87 | 1.56 |
| DPS(Rs) | 0.09 | 0.11 | 0.11 | 0 | 0.09 | 0.37 | 0.5 | 0.64 | 0 | 0 | 0 |
| Book NAV/Share(Rs) | 10.91 | 13.45 | 14.02 | 14.46 | 16.97 | 19.45 | 22.49 | 26.35 | 23.39 | 19.34 | 29.1 |
| Core EBITDA Margin(%) | 7.23 | 6.52 | 5.36 | 0.51 | 5.87 | 8.65 | 7.7 | 8.01 | 0.55 | -4.9 | 5.52 |
| EBIT Margin(%) | 6.17 | 8.31 | 5.64 | 2.37 | 5.23 | 8.61 | 7.09 | 7.48 | -0.03 | -3.89 | 3.16 |
| Pre Tax Margin(%) | 1.38 | 3.78 | 1.78 | -1.56 | 2.36 | 6.27 | 5.59 | 5.47 | -3.69 | -8.55 | 0.54 |
| PAT Margin (%) | 1.14 | 3.91 | 1.34 | -0.8 | 1.65 | 4.28 | 4.11 | 4.04 | -2.84 | -6.61 | 0.26 |
| Cash Profit Margin (%) | 4.6 | 7.29 | 3.62 | 1.55 | 4.01 | 6.4 | 5.51 | 5.24 | -1.53 | -4.52 | 2.06 |
| ROA(%) | 1.38 | 5.15 | 1.69 | -0.95 | 1.96 | 5.23 | 5.86 | 5.53 | -3.16 | -6.16 | 0.36 |
| ROE(%) | 4.86 | 15.75 | 4.94 | -2.76 | 5.39 | 13.19 | 16.26 | 17.93 | -10.9 | -19.75 | 0.83 |
| ROCE(%) | 11.59 | 16.15 | 10.65 | 4.22 | 9.54 | 16.62 | 15.52 | 15.25 | -0.04 | -5.12 | 6.2 |
| Receivable days | 96.58 | 89.4 | 107 | 116.9 | 112.77 | 106.5 | 88.44 | 101.07 | 135.6 | 136.33 | 75.54 |
| Inventory Days | 87.11 | 86.27 | 87.23 | 89.85 | 69.86 | 60.17 | 65.35 | 70.08 | 73.9 | 81.26 | 57.29 |
| Payable days | 124.65 | 111.46 | 112.74 | 115.23 | 114.74 | 118.91 | 92.96 | 95.78 | 115.45 | 135.09 | 98.11 |
| PER(x) | 31.71 | 13.41 | 53.36 | 0 | 25.66 | 14.62 | 21.94 | 17.14 | 0 | 0 | 637.62 |
| Price/Book(x) | 1.66 | 1.91 | 2.58 | 1.9 | 1.2 | 1.79 | 3.31 | 2.84 | 2.21 | 4.82 | 4.27 |
| Dividend Yield(%) | 0.51 | 0.45 | 0.32 | 0 | 0.45 | 1.05 | 0.68 | 0.86 | 0 | 0 | 0 |
| EV/Net Sales(x) | 0.76 | 0.87 | 1 | 0.81 | 0.56 | 0.73 | 1.25 | 1.07 | 1.04 | 1.93 | 2.01 |
| EV/Core EBITDA(x) | 7.08 | 9.04 | 12.5 | 17.72 | 7.52 | 6.81 | 13.18 | 11.21 | 72.18 | -43.48 | 30.11 |
| Net Sales Growth(%) | -7.22 | 6.22 | 15.24 | 2.22 | 17.26 | 17.39 | 37.1 | 29.52 | -15.92 | -30.6 | 28.35 |
| EBIT Growth(%) | 5.3 | 45.39 | -29.62 | -58.06 | 159 | 93.29 | 23.31 | 38.94 | -100.33 | -9260.34 | 203.26 |
| PAT Growth(%) | 16.1 | 270.2 | -64.57 | -160.07 | 340.86 | 204.6 | 43.99 | 29.22 | -162.07 | -56.44 | 104.96 |
| EPS Growth(%) | 16.64 | 235.08 | -64.62 | -156.09 | 309.34 | 199 | 42.46 | 28.89 | -161.95 | -54.89 | 104.65 |
| Debt/Equity(x) | 1.25 | 0.93 | 0.99 | 0.8 | 0.73 | 0.48 | 1.08 | 1.26 | 1.55 | 0.93 | 0.44 |
| Current Ratio(x) | 1.17 | 1.25 | 1.23 | 1.28 | 1.25 | 1.52 | 1.36 | 1.27 | 1.13 | 0.97 | 1.27 |
| Quick Ratio(x) | 0.65 | 0.68 | 0.76 | 0.77 | 0.95 | 1.03 | 0.87 | 0.83 | 0.82 | 0.57 | 0.84 |
| Interest Cover(x) | 1.29 | 1.83 | 1.46 | 0.6 | 1.82 | 3.67 | 4.75 | 3.71 | -0.01 | -0.84 | 1.21 |
| Total Debt/Mcap(x) | 0.75 | 0.49 | 0.38 | 0.42 | 0.61 | 0.27 | 0.33 | 0.44 | 0.7 | 0.19 | 0.1 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 63.72 | 63.65 | 63.65 | 63.65 | 63.08 | 63.08 | 53.09 | 53.74 | 53.7 | 53.69 |
| FII | 0.28 | 0.31 | 0.18 | 0.17 | 0.12 | 0.03 | 0.17 | 0.02 | 0.05 | 0.09 |
| DII | 0.96 | 0.89 | 0 | 0 | 0 | 1.74 | 1.32 | 1.42 | 1.46 | 1.32 |
| Public | 35.04 | 35.15 | 36.16 | 36.18 | 36.8 | 35.15 | 45.43 | 44.83 | 44.79 | 44.9 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 12.69 | 12.69 | 12.69 | 12.69 | 12.69 | 12.69 | 10.69 | 12.58 | 12.58 | 12.58 |
| FII | 0.06 | 0.06 | 0.04 | 0.03 | 0.02 | 0.01 | 0.03 | 0 | 0.01 | 0.02 |
| DII | 0.19 | 0.18 | 0 | 0 | 0 | 0.35 | 0.27 | 0.33 | 0.34 | 0.31 |
| Public | 6.98 | 7.01 | 7.21 | 7.21 | 7.41 | 7.07 | 9.15 | 10.49 | 10.49 | 10.52 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 19.92 | 19.94 | 19.94 | 19.94 | 20.12 | 20.12 | 20.14 | 23.4 | 23.42 | 23.42 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | +28% | -9% | +6% | +9% |
| Operating Profit CAGR | — | -19% | -4% | +4% |
| PAT CAGR | — | -63% | -37% | -6% |
| Share Price CAGR | -35% | +21% | +13% | +19% |
| ROE Average | +1% | -10% | +1% | +4% |
| ROCE Average | +6% | 0% | +6% | +9% |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 63.72 | 63.65 | 63.65 | 63.65 | 63.08 | 63.08 | 53.09 | 53.74 | 53.7 | 53.69 |
| FII | 0.28 | 0.31 | 0.18 | 0.17 | 0.12 | 0.03 | 0.17 | 0.02 | 0.05 | 0.09 |
| DII | 0.96 | 0.89 | 0 | 0 | 0 | 1.74 | 1.32 | 1.42 | 1.46 | 1.32 |
| Public | 35.04 | 35.15 | 36.16 | 36.18 | 36.8 | 35.15 | 45.43 | 44.83 | 44.79 | 44.9 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 12.69 | 12.69 | 12.69 | 12.69 | 12.69 | 12.69 | 10.69 | 12.58 | 12.58 | 12.58 |
| FII | 0.06 | 0.06 | 0.04 | 0.03 | 0.02 | 0.01 | 0.03 | 0 | 0.01 | 0.02 |
| DII | 0.19 | 0.18 | 0 | 0 | 0 | 0.35 | 0.27 | 0.33 | 0.34 | 0.31 |
| Public | 6.98 | 7.01 | 7.21 | 7.21 | 7.41 | 7.07 | 9.15 | 10.49 | 10.49 | 10.52 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 19.92 | 19.94 | 19.94 | 19.94 | 20.12 | 20.12 | 20.14 | 23.4 | 23.42 | 23.42 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
Your relationship manager will connect with you shortly.